Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Local Tumor Microenvironment Niches Correlate With Survival And Immunotherapy Response In Human Glioblastoma.

bioRxiv : the preprint server for biology·2026

Same author

mTORC1 activity suppresses ferroptosis through a SCARB1-dependent HDL-tocopherol uptake pathway.

Molecular cell·2026

Same author

Human stem cell models for group 3 medulloblastoma uncover JARID1B as a regulator of the chromatin landscape.

bioRxiv : the preprint server for biology·2025

Same author

Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models.

Nature genetics·2025

Same author

NOVA: a novel R-package enabling multi-parameter analysis and visualization of neural activity in MEA recordings.

bioRxiv : the preprint server for biology·2025

Same author

Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma.

The Journal of experimental medicine·2025

Search research articles

Related Experiment Video

Updated: May 7, 2026

Zebrafish Model of Neuroblastoma Metastasis

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

Neuroblastoma and MYCN.

Miller Huang¹, William A Weiss

¹Departments of Neurology, Pediatrics, and Neurosurgery, University of California, San Francisco, California 94158-9001.

Cold Spring Harbor Perspectives in Medicine

|October 3, 2013

Summary

Neuroblastoma, a common childhood cancer, often involves MYCN gene amplification, indicating high-risk disease. This review explores MYCN

Area of Science:

Pediatric Oncology
Cancer Genetics
Molecular Biology

Background:

Neuroblastoma is the most frequent pediatric extracranial solid tumor, originating from neural crest cells.
MYCN gene amplification occurs in approximately 25% of neuroblastoma cases.
MYCN amplification is a key indicator of high-risk neuroblastoma and poor patient prognosis.

Purpose of the Study:

To review the established roles of MYCN in neuroblastoma development and progression.
To highlight recently identified driver mutations beyond MYCN in neuroblastoma.
To discuss therapeutic strategies targeting MYCN at the protein stability and transcriptional levels.

Main Methods:

Literature review of existing research on MYCN in neuroblastoma.
Analysis of recent studies identifying novel driver mutations.

More Related Videos

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

Related Experiment Videos

Last Updated: May 7, 2026

Zebrafish Model of Neuroblastoma Metastasis

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

Review of emerging therapeutic approaches targeting MYCN.

Main Results:

MYCN amplification remains the most significant genetic marker for risk stratification in neuroblastoma.
Recent research has identified additional genetic alterations contributing to neuroblastoma pathogenesis.
Novel strategies are being developed to inhibit MYCN function through protein stabilization and transcriptional control.

Conclusions:

Understanding MYCN's multifaceted roles is crucial for neuroblastoma treatment.
Identifying and targeting other driver mutations may offer new therapeutic avenues.
Developing drugs that modulate MYCN protein stability or transcription holds promise for improving outcomes in high-risk neuroblastoma.